Heparin	0	7	B-Drug_or_compound
immobilized	8	19	O
porous	20	26	O
PLGA	27	31	B-Drug_or_compound
microspheres	32	44	O
for	45	48	O
angiogenic	49	59	O
growth	60	66	O
factor	67	73	O
delivery	74	82	O
.	82	83	O

PURPOSE	85	92	O
:	92	93	O
Heparin	94	101	B-Drug_or_compound
immobilized	102	113	O
porous	114	120	O
poly	121	125	B-Drug_or_compound
(	125	126	I-Drug_or_compound
D	126	127	I-Drug_or_compound
,	127	128	I-Drug_or_compound
L	128	129	I-Drug_or_compound
-	129	130	I-Drug_or_compound
lactic	130	136	I-Drug_or_compound
-	136	137	I-Drug_or_compound
co	137	139	I-Drug_or_compound
-	139	140	I-Drug_or_compound
glycolic	140	148	I-Drug_or_compound
acid	149	153	I-Drug_or_compound
)	153	154	I-Drug_or_compound
(	155	156	O
PLGA	156	160	B-Drug_or_compound
)	160	161	O
microspheres	162	174	O
were	175	179	O
prepared	180	188	O
for	189	192	O
sustained	193	202	O
release	203	210	O
of	211	213	O
basic	214	219	B-Gene_or_gene_product
fibroblast	220	230	I-Gene_or_gene_product
growth	231	237	I-Gene_or_gene_product
factor	238	244	I-Gene_or_gene_product
(	245	246	O
bFGF	246	250	B-Gene_or_gene_product
)	250	251	O
to	252	254	O
induce	255	261	O
angiogenesis	262	274	O
.	274	275	O

MATERIALS	276	285	O
AND	286	289	O
METHODS	290	297	O
:	297	298	O
Porous	299	305	O
PLGA	306	310	B-Drug_or_compound
microspheres	311	323	O
having	324	330	O
primary	331	338	O
amine	339	344	O
groups	345	351	O
on	352	354	O
the	355	358	O
surface	359	366	O
were	367	371	O
prepared	372	380	O
using	381	386	O
an	387	389	O
oil	390	393	O
-	393	394	O
in	394	396	O
-	396	397	O
water	397	402	O
(	403	404	O
O	404	405	O
/	405	406	O
W	406	407	O
)	407	408	O
single	409	415	O
emulsion	416	424	O
method	425	431	O
using	432	437	O
Pluronic	438	446	O
F	447	448	O
-	448	449	O
127	449	452	O
as	453	455	O
an	456	458	O
extractable	459	470	O
porogen	471	478	O
.	478	479	O

Heparin	480	487	B-Drug_or_compound
was	488	491	O
surface	492	499	O
immobilized	500	511	O
via	512	515	O
covalent	516	524	O
conjugation	525	536	O
.	536	537	O

bFGF	538	542	B-Gene_or_gene_product
was	543	546	O
loaded	547	553	O
into	554	558	O
the	559	562	O
heparin	563	570	B-Drug_or_compound
functionalized	571	585	O
(	586	587	O
PLGA	587	591	B-Drug_or_compound
-	591	592	O
heparin	592	599	B-Drug_or_compound
)	599	600	O
microspheres	601	613	O
by	614	616	O
a	617	618	O
simple	619	625	O
dipping	626	633	O
method	634	640	O
.	640	641	O

The	642	645	O
bFGF	646	650	B-Gene_or_gene_product
loaded	651	657	O
PLGA	658	662	B-Drug_or_compound
-	662	663	O
heparin	663	670	B-Drug_or_compound
microspheres	671	683	O
were	684	688	O
tested	689	695	O
for	696	699	O
in	700	702	O
vitro	703	708	O
release	709	716	O
and	717	720	O
in	721	723	O
vivo	724	728	O
angiogenic	729	739	O
activity	740	748	O
.	748	749	O

RESULTS	750	757	O
:	757	758	O
PLGA	759	763	B-Drug_or_compound
microspheres	764	776	O
with	777	781	O
an	782	784	O
open	785	789	O
-	789	790	O
porous	790	796	O
structure	797	806	O
were	807	811	O
formed	812	818	O
.	818	819	O

The	820	823	O
amount	824	830	O
of	831	833	O
conjugated	834	844	O
amine	845	850	O
group	851	856	O
onto	857	861	O
the	862	865	O
microspheres	866	878	O
was	879	882	O
1	883	884	O
.	884	885	O
93	885	887	O
+	887	888	O
/	888	889	O
-	889	890	O
0	890	891	O
.	891	892	O
01	892	894	O
nmol	895	899	O
/	899	900	O
mg	900	902	O
-	902	903	O
microspheres	903	915	O
,	915	916	O
while	917	922	O
the	923	926	O
amount	927	933	O
of	934	936	O
heparin	937	944	B-Drug_or_compound
was	945	948	O
95	949	951	O
.	951	952	O
8	952	953	O
pmol	954	958	O
/	958	959	O
mg	959	961	O
-	961	962	O
microspheres	962	974	O
.	974	975	O

PLGA	976	980	B-Drug_or_compound
-	980	981	O
heparin	981	988	B-Drug_or_compound
microspheres	989	1001	O
released	1002	1010	O
out	1011	1014	O
bFGF	1015	1019	B-Gene_or_gene_product
in	1020	1022	O
a	1023	1024	O
more	1025	1029	O
sustained	1030	1039	O
manner	1040	1046	O
with	1047	1051	O
a	1052	1053	O
smaller	1054	1061	O
extent	1062	1068	O
of	1069	1071	O
initial	1072	1079	O
burst	1080	1085	O
than	1086	1090	O
PLGA	1091	1095	B-Drug_or_compound
microspheres	1096	1108	O
,	1108	1109	O
indicating	1110	1120	O
that	1121	1125	O
surface	1126	1133	O
immobilized	1134	1145	O
heparin	1146	1153	B-Drug_or_compound
controlled	1154	1164	O
the	1165	1168	O
release	1169	1176	O
rate	1177	1181	O
of	1182	1184	O
bFGF	1185	1189	B-Gene_or_gene_product
.	1189	1190	O

Subcutaneous	1191	1203	O
implantation	1204	1216	O
of	1217	1219	O
bFGF	1220	1224	B-Gene_or_gene_product
loaded	1225	1231	O
PLGA	1232	1236	B-Drug_or_compound
-	1236	1237	O
heparin	1237	1244	B-Drug_or_compound
microspheres	1245	1257	O
in	1258	1260	O
mice	1261	1265	B-Organism
significantly	1266	1279	O
induced	1280	1287	O
the	1288	1291	O
formation	1292	1301	O
of	1302	1304	O
new	1305	1308	O
vascular	1309	1317	B-Tissue
microvessels	1318	1330	I-Tissue
.	1330	1331	O

CONCLUSIONS	1332	1343	O
:	1343	1344	O
PLGA	1345	1349	B-Drug_or_compound
microspheres	1350	1362	O
with	1363	1367	O
an	1368	1370	O
open	1371	1375	O
porous	1376	1382	O
structure	1383	1392	O
allowed	1393	1400	O
significant	1401	1412	O
amount	1413	1419	O
of	1420	1422	O
heparin	1423	1430	B-Drug_or_compound
immobilization	1431	1445	O
and	1446	1449	O
bFGF	1450	1454	B-Gene_or_gene_product
loading	1455	1462	O
.	1462	1463	O

bFGF	1464	1468	B-Gene_or_gene_product
loaded	1469	1475	O
PLGA	1476	1480	B-Drug_or_compound
-	1480	1481	O
HP	1481	1483	B-Drug_or_compound
microspheres	1484	1496	O
showed	1497	1503	O
sustained	1504	1513	O
release	1514	1521	O
profiles	1522	1530	O
of	1531	1533	O
bFGF	1534	1538	B-Gene_or_gene_product
in	1539	1541	O
vitro	1542	1547	O
,	1547	1548	O
demonstrating	1549	1562	O
reversible	1563	1573	O
and	1574	1577	O
specific	1578	1586	O
binding	1587	1594	O
of	1595	1597	O
bFGF	1598	1602	B-Gene_or_gene_product
to	1603	1605	O
immobilized	1606	1617	O
heparin	1618	1625	B-Drug_or_compound
.	1625	1626	O

They	1627	1631	O
also	1632	1636	O
induced	1637	1644	O
local	1645	1650	O
angiogenesis	1651	1663	O
in	1664	1666	O
vivo	1667	1671	O
in	1672	1674	O
an	1675	1677	O
animal	1678	1684	O
model	1685	1690	O
.	1690	1691	O

